Home

Monday, August 21, 2017 - 16:03
Follow these 7 simple steps to find the right fulfillment partner.Selecting a fulfillment provider goes deeper than finding a warehouse to store product; it’s about understanding your brand’s requirements and ultimately matching with a partner that can meet your needs. But what should you look for when sourcing a partner? We consulted Chris Mushinsky, vice president of Warwick Fulfillment Solutions (with more than 15 years of experience under her belt) to find out.
http://beautystorebusiness.com/warehouse-shopping-101
Monday, August 21, 2017 - 15:37
Crack the Instagram code with our best marketing tips for this top social-media platform.It’s hard to remember the days before social media. How did humans keep in touch with friends, both disparate and distant, prior to the dawn of Facebook? Did presidents really once opine via platforms that allowed for more than 140 characters? As a modern civilization, we’re plugged in—which means that across the board and regardless of profession, social engagement is ubiquitous.
http://beautystorebusiness.com/insta-results
Friday, August 18, 2017 - 12:05
12 problem-solving haircare ingredients. Beauty store and salon owners, take note.While common sense may suggest that there’s no such thing as having too many choices, human nature dictates the opposite. Take the famous jam study, wherein sociologists set up two displays at a gourmet store. The first contained six preserve options, the other boasted an array of 24. All customers were offered a dollar-off coupon if they bought a jar. In the end, 30 percent of shoppers exposed to the smaller selection took home jelly, while only three percent of the latter group made a purchase.
http://beautystorebusiness.com/natural-selection

Advertisement - Box 1

Advertisement - Box 2

Thursday, August 17, 2017 - 14:14
A mouse study from the O’Donnell Brain Institute and University of California, Irvine, showed that eating at abnormal times disrupts the circadian rhythm of the skin and alters the potency of an enzyme that protects it against ultraviolet radiation.
http://medestheticsmag.com/eating-habits-affect-skin%E2%80%99s-ability-protect-itself-against-uv-rays
Thursday, August 17, 2017 - 14:14
A mouse study from the O’Donnell Brain Institute and University of California, Irvine, showed that eating at abnormal times disrupts the circadian rhythm of the skin and alters the potency of an enzyme that protects it against ultraviolet radiation.
http://medestheticsmag.com/eating-habits-affect-skin%E2%80%99s-ability-protect-itself-against-uv-rays
Thursday, August 17, 2017 - 14:12
A review study published in the September 2017 issue of the Journal of the American Academy of Dermatology supports the role of Demodex mites in rosacea. Ying Shuo-Chang, MD, and Yu-Chen Huang, MD, of Taipei Medical University Hospital, Taiwan, performed a literature search in PubMed, MEDLINE, and EmBase databases from inception through October 31, 2016. They searched the terms “Demodex” and “Demodex Mites” combined with “Rosacea.” All studies included in their review and meta-analysis were human clinical trials published in English.
http://medestheticsmag.com/new-evidence-demodex-mite-infestations-rosacea

Advertisement - Box 3

Advertisement - Box 4

Thursday, August 10, 2017 - 11:49
Larry Brilliant, MD, MPH, will deliver the opening keynote address at the 2017 Annual Meeting of the American Society for Dermatologic Surgery (ASDS) on October 5 in Chicago.
http://medestheticsmag.com/larry-brilliant-md-open-2017-asds-meeting
Thursday, August 10, 2017 - 11:00
Bonti, a clinical-stage biotechnology company, has announced topline results of the first clinical study of its lead product candidate, EB-001, in glabellar lines. EB-001 is a novel serotype E botulinum neurotoxin with a unique efficacy profile, characterized by fast onset of action (about 24 hours) and short duration of effect (about 4 weeks).
http://medestheticsmag.com/bonti-releases-phase-2a-clinical-study-data-its-botulinum-toxin-product
Thursday, August 10, 2017 - 11:00
Bonti, a clinical-stage biotechnology company, has announced topline results of the first clinical study of its lead product candidate, EB-001, in glabellar lines. EB-001 is a novel serotype E botulinum neurotoxin with a unique efficacy profile, characterized by fast onset of action (about 24 hours) and short duration of effect (about 4 weeks).
http://medestheticsmag.com/bonti-releases-phase-2a-clinical-study-data-its-botulinum-toxin-product

Pages

Advertisement - Box 5

Advertisement - Box 6